Scholars Central

Research articlePublished 27 Feb 2015

Determination of the ability of Gangliosides as expected inhibitors of naja toxin PLA2 (NV-PLA2) prompted human erythrocyte film harm

Authors: ZhiXia Mu, Jun Zhou

Advances in Life Science and Biotechnology

Volume 3 · Issue 1 · Pages 8–14

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We determined the ability of mixed gangliosides (16% GD1b, 19% GT1b, 21% GM1, and 40% GD1a) and individual gangliosides GM1 and GD1b to modulate the NV-PLA2 induced human erythrocyte ghost membrane damage. CM-Sephadex purification of crude Naja naja venom yielded eight peaks of which peak VII, a major phospholipase A2 (NV-PLA2) accounted for 22% of the total protein recovered and 8% of the total PLA2 activity recovered. The membrane damage induced by NV-PLA2 was assessed by measuring the decrease in the relative intensity of fluorescence using cis–parinaric acid (PnA) as a monitor molecule. The RBC membranes isolated from healthy human blood showed 72% damage on treatment with NV-PLA2 (2 g) when compared to untreated membranes. Mixed gangliosides (18 nM) and GM1 (15 nM) offered 81 and 86% protection respectively, whereas GD1b (20 nM) did not show significant protection. Analysis of membrane bound Na+ K + and Ca2+Mg2+ ATPase indicated a 3 fold and 2 folds decrease in their activities on NV-PLA2 treatment when compared to untreated membranes. Mixed gangliosides restored the Na+ K + ATPase activity by 78%, whereas GM1 and GD1b offered 74 and 52% restoration respectively. The Ca2+Mg 2+ ATPase activity was restored by 80 and 81% with mixed gangliosides and GM1 respectively. GD1b showed only 50% restoration. Mixed gangliosides and GM1 exhibited a significant dose dependent inhibition of NV-PLA2 activity when compared to GD1b. The data show that mixed gangliosides and GM1 were effective in modulating NV-PLA2 induced erythrocyte membrane damage than GD1b.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Advances in Life Science and Biotechnology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Life Science and Biotechnology
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “ZhiXia Mu”
  • BylineArticles whose byline prints “Jun Zhou”